“October is going to be a very exciting month in the U.S., regarding COVID-19 vaccines,” says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group.
“On the 14th of this month, the Federal Drug Administration (FDA) is going to look at COVID-19 boosters for Moderna, on the 15th, boosters for Johnson & Johnsons’ COVID-19 vaccine, and on the 29th of October the FDA will look at extending Emergency Use for the Pfizer COVID-19 vaccine for children down to five years of age,” says Dr. Poland. He adds that immunizing children could begin within a couple of weeks of the EU approval.
Dr. Poland also says approval of Merck’s antiviral COVID-19 pill is expected soon, too.
“We are excited about this because it’s oral and doesn’t need to be administered by injection or IV infusion,” says Dr. Poland. “The nice part about this is you can take it at home and it fits with the same paradigm we already have in clinical medicine, treating influenza with an antiviral.”
In this Mayo Clinic Q&A podcast, Dr. Poland also talks about waning immunities, the approval possibility of mixing and matching COVID-19 booster vaccines and he reminds women who are pregnant to get a COVID-19 vaccine.